Part 1 Stage I - Triple-negative breast cancer (TNBC)
This Medudy Master Class Series is a video tutorial for physicians on the topic of "Treatment of triple-negative breast cancer (TNBC)". This first part, presented by Prof. Dr. Sherko Kümmel, highlights the treatment of stage I TNBC and discusses key questions on treatment standards, the use of neoadjuvant chemotherapy and de-escalation strategies for small tumors. A [...]
Endometrial carcinoma
This Medudy Masterclass is a five-part video tutorial for doctors on the topic of endometrial cancer. In this video series, Prof. Dr. Fabian Trillsch presents the key treatment decisions and new therapeutic approaches in endometrial cancer. The following topics are covered: The first part deals with the diagnosis of endometrial carcinoma as a basis for therapy planning. The second part [...]
Increased risk of recurrence in giant cell arteritis with mosaic loss of the Y chromosome
This Medudy course is a video tutorial for physicians on the topic "Increased risk of recurrence in giant cell arteritis with mosaic loss of the Y chromosome". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Mosaic loss of the Y chromosome (mLOY) is the most common acquired somatic [...]
The role of mLOY in giant cell arteritis
This Medudy "Expert Opinion" is a video tutorial for physicians on "The role of mLOY in giant cell arteritis" presented by Dr. Peer Aries, rheumatologist and immunologist at the Immunologikum in Hamburg. New findings on the role of mosaic loss of the Y chromosome (mLOY) in giant cell arteritis will be presented. A clinical case will be discussed and the current study situation [...]
Infections in immunocompromised patients
This Medudy Expert Opinion is a video tutorial for physicians on the topic of "Infections in immunocompromised patients" presented by Dr. Peer Aries, head of the Immunologikum in Hamburg, a specialist center for rheumatology and immunology. Patients with autoimmune diseases undergoing immunosuppressive treatment have a significantly increased risk of serious infections and infection-related deaths. Patient-related and therapy-related risk factors are discussed, [...]
Guideline-Directed Medical Therapy in Heart Failure: Urgency Across the Ejection Fraction Spectrum
This Medudy course is a video tutorial for physicians on the topic "Guideline-based therapy of heart failure: need for action across the entire spectrum of ejection fraction". Heart failure is a progressive, life-threatening disease that remains one of the leading causes of hospitalization and death worldwide. Despite significant therapeutic advances, treatment success remains poor. [...]
Guideline-based therapy of heart failure: need for action across the entire spectrum of ejection fraction
This Medudy course is a video tutorial for physicians on the topic "Guideline-based therapy of heart failure: need for action across the entire spectrum of ejection fraction". Heart failure is a progressive, life-threatening disease that remains one of the leading causes of hospitalization and death worldwide. Despite significant therapeutic advances, treatment success remains poor. [...]
Urgency and opportunity in heart failure: High-intensity guideline-based therapy across the entire spectrum of ejection fraction
This Medudy course is a video tutorial for physicians on "Urgency and opportunity in heart failure: High-intensity guideline-based therapy across the ejection fraction spectrum". Heart failure is a growing health problem worldwide, characterized by high hospitalization rates and mortality comparable to cancer. Despite remarkable advances in treatment, the majority of [...]
mHSPC - Metastatic hormone-sensitive prostate cancer
This is a Medudy Master Series on prostate cancer. This module highlights the key aspects of metastatic hormone-sensitive prostate cancer (mHSPC) and is presented by Prof. Dr. Axel Merseburger, Director of the Department of Urology at the Lübeck Campus of the University Medical Center Schleswig-Holstein. The course is divided into four parts: The first part deals with the epidemiology and staging [...]
Biosimilars
The Medudy course on biosimilars, presented by Professor Axel Merseburger, Director of the Clinic for Urology at the University of Lübeck, provides practical knowledge on the development, approval and use of biosimilars in everyday clinical practice.Biosimilars are follow-on preparations of biologics which, due to their complex production in biological systems, are not identical copies, but only highly comparable products. [...]